Hélder A. Santos
University of Helsinki
Research line: Nano
Role in project: Nanomedicines, Drug Delivery, Biomedical Engineering, Heart Diseases
Dr. Hélder A. Santos is a physical chemist specialized in electrochemistry, biological mimetic models and soft interfaces. Currently, he is a Full Professor in Pharmaceutical Nanotechnology, Principal Investigator/Group Leader, Head of the Nanomedicine and Biomedical Engineering Group, former Head of the Division of Pharmaceutical Chemistry and Technology, and former Head of the Preclinical Drug Formulation and Analysis Group at the Faculty of Pharmacy, University of Helsinki. He is also the Director of the Doctoral Programme in Drug Research at the Faculty of Pharmacy, University of Helsinki, and the Director of the FinPharmaNet. Dr. Santos’ research is focused on nanobiomaterials, including nanoporous silica/silicon materials and polymeric-based nanoparticles for controlled drug delivery, diagnostics and therapy. The research interests include the development of nanoparticles/nanomedicines for biomedical and healthcare applications. His current work makes the bridge between engineering, pharmaceutical and medical research. His main research focus is in the use of biodegradable and biocompatible nanoporous silicon nanomaterials, polymers, the application of microfluidics technology for nanoparticle production for simultaneous controlled drug delivery, diagnostic and treatment of cancer, diabetes, and cardiovascular diseases, and further translation of these nanotechnologies into the clinic.